DETECTION OF BORRELIACIDAL ANTIBODIES BY FLOW-CYTOMETRY - AN ACCURATE, HIGHLY SPECIFIC SERODIAGNOSTIC TEST FOR LYME-DISEASE

被引:26
作者
CALLISTER, SM
SCHELL, RF
LIM, LCL
JOBE, DA
CASE, KL
BRYANT, GL
MOLLING, PE
机构
[1] GUNDERSEN CLIN, DEPT RHEUMATOL, LA CROSSE, WI USA
[2] UNIV WISCONSIN, DEPT BACTERIOL, MADISON, WI 53706 USA
[3] UNIV WISCONSIN, DEPT MED MICROBIOL & IMMUNOL, MADISON, WI 53706 USA
[4] UNIV WISCONSIN, WISCONSIN STATE LAB HYG, MADISON, WI 53706 USA
关键词
D O I
10.1001/archinte.154.14.1625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Borreliacidal antibodies can be detected in serum samples from patients with early or late Lyme disease symptoms. When these serum samples are incubated with Borrelia burgdorferi and complement, spirochetes are rapidly killed. Detection of these antibodies can be used as a serodiagnostic test. Methods: Individual serum samples containing IgM or IgG borreliacidal antibodies were used to develop a method for detection using flow cytometry. An additional 10 case-defined Lyme disease serum samples and 10 normal serum samples were used to confirm appropriate flow cytometric parameters. To determine specificity, 157 normal serum samples and 104 potential cross-reactive serum samples were tested for borreliacidal activity and antibodies to B burgdorferi using indirect fluorescent antibody or enzyme immunoassay. Results: Flow cytometry can be used to detect borreliacidal activity within 16 to 24 hours after incubation of B burgdorferi organisms, Lyme disease serum, and complement. Significant borreliacidal activity was detected in all Lyme disease serum samples. The percentages of positive normal serum samples were comparable (6% to 10%) using all three assays. In addition, the indirect fluorescent antibody and enzyme immunoassay identified 41 (39%) and 47 (45%) potential cross-reactive serum samples as positive, respectively. In contrast, significant borreliacidal activity was not detected in any potential cross-reactive serum samples. Conclusion: Detection of borreliacidal antibody, unlike indirect fluorescent antibody and enzyme immunoassay, is an accurate, highly specific serodiagnostic test for detection of Lyme disease.
引用
收藏
页码:1625 / 1632
页数:8
相关论文
共 49 条
[1]   LYME-DISEASE - CLINICAL-FEATURES, CLASSIFICATION, AND EPIDEMIOLOGY IN THE UPPER MIDWEST [J].
AGGER, W ;
CASE, KL ;
BRYANT, GL ;
CALLISTER, SM .
MEDICINE, 1991, 70 (02) :83-90
[2]  
BAKKEN L, 1993, AM SOC MICROBIOLOGY
[3]   PERFORMANCE OF 45 LABORATORIES PARTICIPATING IN A PROFICIENCY TESTING PROGRAM FOR LYME-DISEASE SEROLOGY [J].
BAKKEN, LL ;
CASE, KL ;
CALLISTER, SM ;
BOURDEAU, NJ ;
SCHELL, RF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (07) :891-895
[4]  
BARBOUR AG, 1984, YALE J BIOL MED, V57, P521
[5]   BIOLOGY OF BORRELIA SPECIES [J].
BARBOUR, AG ;
HAYES, SF .
MICROBIOLOGICAL REVIEWS, 1986, 50 (04) :381-400
[6]   LYME-DISEASE ASSAY WHICH DETECTS KILLED BORRELIA-BURGDORFERI [J].
CALLISTER, SM ;
SCHELL, RF ;
LOVRICH, SD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :1773-1776
[7]   CHARACTERIZATION OF THE BORRELIACIDAL ANTIBODY-RESPONSE TO BORRELIA-BURGDORFERI IN HUMANS - A SERODIAGNOSTIC TEST [J].
CALLISTER, SM ;
SCHELL, RF ;
CASE, KL ;
LOVRICH, SD ;
DAY, SP .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :158-164
[8]   EFFECTS OF BOVINE SERUM-ALBUMIN ON THE ABILITY OF BARBOUR-STOENNER-KELLY MEDIUM TO DETECT BORRELIA-BURGDORFERI [J].
CALLISTER, SM ;
CASE, KL ;
AGGER, WA ;
SCHELL, RF ;
JOHNSON, RC ;
ELLINGSON, JLE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (02) :363-365
[9]  
Chapin-Robertson K, 1991, ANTIBIOTICS LAB MED, P295
[10]  
CHU HJ, 1992, J AM VET MED ASSOC, V201, P403